Cameron Wheeler

Cameron Wheeler

Signal active

Principal

Bio

Cameron is a Principal on the Private Transactions team at Deerfield. Cameron joined Deerfield in 2014 and focuses on therapeutics companies. Prior to joining Deerfield, Cameron was at Eleven Biotherapeutics for more than five years, where he was responsible for corporate development and commercial strategy. He was instrumental in the founding, building, and the eventual public offering of Eleven Biotherapeutics. Prior to Eleven, Cameron was at Third Rock Ventures, a Boston-based venture capital firm focused on launching and building life science companies. While at Third Rock, Cameron gained business development and operating experience as a member of the founding team of Constellation Pharmaceuticals. Cameron holds a Ph.D. and S.M. in Biological Engineering and an S.B. in Mechanical Engineering from Massachusetts Institute of Technology.

Location

New York, New York, United States, North America

Social

Primary Organization

Deerfield

Deerfield

Founded

1994

Investment

271

Lead investment

143

Exits

128

Employees

101-250

Industry

Financial Services, Venture Capital, Impact Investing, Hedge Funds

Jobs history

2

Vicinitas Therapeutics

Board Member

2022 - Current

Nuvalent

Board Member

Invalid date - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Cameron Wheeler is the Principal at Deerfield, based in New York, New York, United States, North America. With a background in Financial Services, Cameron Wheeler has a rich history of leadership and innovation. Cameron Wheeler studied Ph.D Biological Engineering @ Massachusetts Institute of Technology. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

12

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
May 11, 2021
Nuvalent Nuvalent
Series B - Nuvalent
Nuvalent Deerfield
135.0M
Jun 14, 2021
Ribon Therapeutics Ribon Therapeutics
Series C - Ribon Therapeutics
Ribon Therapeutics Deerfield
65.0M
Jul 28, 2022
Vicinitas Therapeutics Vicinitas Therapeutics
Series A - Vicinitas Therapeutics
Vicinitas Therapeutics Deerfield
65.0M
Jan 05, 2023
Perceive Biotherapeutics Perceive Biotherapeutics
Series B - Perceive Biotherapeutics
Perceive Biotherapeutics Deerfield
78.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.